Oct 8 2010
Codexis Inc, a company known for its biocatalyst products, has declared the extension of its Codex Panels production line with the debut of its Codex Screening Kits. The kits are formulated utilizing its well known Codex Panels biocatalyst screening plates and can be utilized along with them.
The Codex Panels are utilized by a number of fine chemical and pharmaceutical companies all over the world including the known names such as Merck and Roche. The product lessens the development time during the manufacturing process and reduces the costs.
The Codex Screening Kits currently introduced by the company comprises a range of 24 top functional enzymes selected from the large biocatalyst variants collection. The kit is offered in a normal vial design for the simple use of the chemists and provided with increased screening potential and utilizes lesser quantity of enzymes than the existing Codex Panels which were introduced during 2007. The newly introduced Codex Screening Kits constitute transaminase and ketoreductase enzymes that are generally used.
Joseph Sarret, Managing Director and President of the company, said that the Codex Panels were put into service four years back and were first utilized by Merck. Now the product is extensively utilized in drug manufacturing companies to improve the production process and output. He added that the newly introduced Codex Screening Kits will facilitate the clients to integrate the technology in their production process in a broader way and all through their expansion process.
Source: http://www.codexis.com/